Liminal Biosciences Inc. (LMNL) Social Stream



Liminal Biosciences Inc. (LMNL): $1.24

-0.11 (-8.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LMNL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 503

in industry

Liminal BioSciences Inc (LMNL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Liminal BioSciences Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $4.5 $2.3 $3.1 $1.6 93.75%

The Trend in the Analyst Price Target


LMNL's average price target has moved up $0.09 over the prior 2 days.

LMNL reports an average of 91.44% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 4 4.49836 2.29916 3.60037 2.52 42.87%
2021-09-20 4 4.55875 2.33003 3.64870 2.52 44.79%
2021-09-20 4 4.59382 2.34795 3.67677 2.52 45.9%
2021-09-20 4 4.59672 2.34943 3.67909 2.52 46%
2021-09-20 4 4.60909 2.35576 3.68899 2.52 46.39%
2021-09-20 4 4.59270 2.34738 3.67588 2.52 45.87%
2021-05-27 4 22.09544 2.81215 9.99288 4.23 136.24%
2021-05-27 4 21.94338 2.79279 9.92411 4.23 134.61%
2021-05-27 4 21.70496 2.76245 9.81628 4.23 132.06%
2021-05-27 4 21.65459 2.75604 9.79350 4.23 131.52%
2021-05-27 4 21.43579 2.72819 9.69455 4.23 129.19%
2021-05-27 4 21.15995 2.69308 9.56980 4.23 126.24%
2021-05-27 4 21.23538 2.70268 9.60391 4.23 127.04%
2020-12-09 0 16.49348 4.63879 10.56538 4.27 147.43%
2020-12-09 2 16.49348 4.63879 10.56538 4.27 147.43%
2020-12-09 0 20.66880 5.81310 13.24000 4.27 210.07%
2020-12-09 2 20.66880 5.81310 13.24000 4.27 210.07%
2020-12-09 0 16.47350 4.63317 10.55258 4.27 147.13%
2020-12-09 2 16.47350 4.63317 10.55258 4.27 147.13%

LMNL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.5 0 0 3 1 1 4

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The average analyst price target of LMNL is higher than 2.09% of all US stocks.
  • LMNL has a less variance in analysts' estimates than 12.13% of all US stocks.
  • Liminal BioSciences Inc's upside potential (average analyst target price relative to current price) is greater than 82.81% of all US stocks.
  • Liminal BioSciences Inc's number of analysts covering the stock is greater than 33.17% of Pharmaceutical Products stocks.

Stocks similar to Liminal BioSciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ENDP, ANAB and ADAP.

Is LMNL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5077 seconds.